TSMHT
DGX icon

Thurston Springer Miller Herd & Titak’s Quest Diagnostics DGX Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-18
Closed -$3.23K – 737
2025
Q2 		$3.23K Hold
18
– – ﹤0.01% 1350
2025
Q1 		$3.04K Buy
+18
New +$2.96K ﹤0.01% 1375

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's DGX Position: Q3 2025 in Review

Thurston Springer Miller Herd & Titak sold out of Quest Diagnostics (DGX) in Q3 2025, closing a stake of 18 shares — an estimated $3.23K sold.

Thurston Springer Miller Herd & Titak first reported a position in DGX in Q1 2025 and held it in 2 quarters. The position peaked at $3.23K in Q2 2025. 1,005 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

  • Thurston Springer Miller Herd & Titak reported no remaining Quest Diagnostics position as of Q3 2025 after selling out during the quarter.
  • Thurston Springer Miller Herd & Titak sold 18 Quest Diagnostics shares in Q3 2025, an estimated $3.23K.
  • Thurston Springer Miller Herd & Titak first reported a position in Quest Diagnostics in Q1 2025 and held it in 2 quarters.
  • Thurston Springer Miller Herd & Titak's Quest Diagnostics position peaked at $3.23K in Q2 2025.
  • 1,005 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q3 2025, filed 7 Oct 2025.